Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

Creative Commons License

Reinmuth N., Goldman J. W., Garassino M. C., Chen Y., Hotta K., Poltoratskiy A., ...More

ANNALS OF ONCOLOGY, vol.33, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 33
  • Publication Date: 2022
  • Doi Number: 10.1016/j.annonc.2022.02.172
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
  • Istanbul University Affiliated: No